Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.8441
Schlusskurs vom Vortag:
$0.8441
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$10.56M
Einnahmen:
$895.50K
Nettoeinkommen (Verlust:
$-26.30M
KGV:
0.00
EPS:
-65.5728
Netto-Cashflow:
$-23.84M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$2.18
Mainz Biomed N V Stock (MYNZ) Company Profile
Firmenname
Mainz Biomed N V
Sektor
Branche
Telefon
-
Adresse
-
Compare MYNZ vs TMO, DHR, IDXX, WAT, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
0.00 | 10.56M | 895.50K | -26.30M | -23.84M | -65.57 |
TMO
Thermo Fisher Scientific Inc
|
448.28 | 167.00B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.00 | 122.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
559.37 | 43.63B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
342.37 | 33.48B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
114.96 | 32.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | Maxim Group | Buy |
| 2024-11-25 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Mainz Biomed N V Aktie (MYNZ) Neueste Nachrichten
From Cancer Tests to Combat Drones: Mainz Biomed's Radical Reinvention Nears a Key Vote - AD HOC NEWS
Mainz Biomed’s Big Pivot: New Name, New Risks, Same Volatility - Finimize
Quantum Cyber's Patent Salvo Drives Stock Rally Amid Insider Share Awards and Cash Concerns - AD HOC NEWS
Guido Baechler files Form 144 to sell 200,000 MYNZ shares (MYNZ) - Stock Titan
Quantum Cyber (QUCY) director files Form 3 reporting zero ordinary shares - Stock Titan
Quantum Cyber (NASDAQ: MYNZ) director awarded 137,141 ordinary shares in Form 4 filing - Stock Titan
Quantum Cyber N.V. and Other Players Eye Potential CHIPS Act Funding From Trump Administration - TradingView
Quantum Cyber forms US defense subsidiary for drone programs - MSN
QUCY Stock Price, Quote & Chart | QUANTUM CYBER NV (NASDAQ:QUCY) - ChartMill
[144] Quantum Cyber N.V. SEC Filing - Stock Titan
Quantum Cyber (MYNZ) inks exclusive IP license with $5M cash and shares - Stock Titan
[10-Q] Quantum Cyber N.V. Quarterly Earnings Report - Stock Titan
Quantum Cyber site spotlights drones as Trump administration seeks $55B - Stock Titan
Quantum Cyber N.V. (QUCY-Q) Stock Price and News - The Globe and Mail
3 Penny Stocks to Watch Now, 5/14/26 - TipRanks
Quantum Cyber Stock Surges As Drone Deal And Ex-VA Chief Put Defense Pivot In Focus - TechStock²
Quantum Cyber appoints former VA acting secretary to board - Investing.com India
Mainz Biomed Stock Surges 315% as QUCY Hits $1.34 on Massive Volume - Meyka
Quantum Cyber N.V.Ordinary Shares (NQ: QUCY - FinancialContent
Quantum Cyber N.V. (QUCY) Stock: Drone Defense Deal Sparks 69% Rally - MEXC Exchange
Quantum Cyber N.V. (QUCY) Stock Soars 69% on BP United Drone Defense Partnership - MEXC Exchange
Cisco, Nokia, Ford, Quantum Cyber And Nebius Group: Why These 5 Stocks Are On Investors' Radars Today - Sahm
TradingKey - TradingKey
MSN Money - MSN
Quantum Cyber (MYNZ) boosts ATM share program to $100M, sets CFO consulting deal - Stock Titan
QUCY (Mainz) beats EPS estimates by 26% yet stock slides 3% despite cost discipline as revenue drops.Barrier to Entry - newser.com
Mainz Biomed changes ticker symbol to QUCY - MSN
QUCY Price History for Mainz Biomed N.V. Stock - Barchart
QUCYQuantum Cyber NV Stock Price and Quote - Finviz
Quantum Cyber N.V. Announces Name Change, Major Investment, and Board Restructuring Following Shareholder Approval - Minichart
Quantum Cyber N.V. (QUCY) director discloses 2,000 Ordinary Shares on Form 3 - Stock Titan
Quantum Cyber N.V. (QUCY) director files Form 3 showing zero share ownership - Stock Titan
Quantum Cyber N.V. completes major financing and governance overhaul - TipRanks
CEO David Lazar expands Quantum Cyber N.V. (NASDAQ: MYNZ) preferred stake - Stock Titan
David Lazar secures control of Mainz Biomed (Nasdaq: MYNZ) with $6M deal - Stock Titan
Quantum Cyber (NASDAQ: MYNZ) outlines change of control and board overhaul - Stock Titan
What will be the closing price of QUCY stocks? - StockInvest.us
Mainz Biomed N.v. Stock Data and SignalsQUCY - StockInvest.us
QUCY Insider Trading (Mainz Biomed N.v. stock) - StockInvest.us
Mainz Biomed N.V. announced that it has received $6 million in funding - marketscreener.com
Mainz (QUCY) Stock Variable Dividend (Grinds Lower) 2026-04-20Shared Momentum Picks - newser.com
QUCY Should I Buy - Intellectia AI
Mainz Biomed Sells Next Gen Colorectal Cancer IP to Focus on Pancreatic Cancer and Post-Quantum Cybersecurity 7 - Minichart
Mainz Biomed NVenters asset purchase agreement on April 9, 2026 for next gen IP saleSEC filing - marketscreener.com
Mainz Biomed (NASDAQ: MYNZ) sells cancer IP and lifts equity above Nasdaq minimum - Stock Titan
Mainz (QUCY) Stock Credit Spread (Craters) 2026-04-15Wall Street Picks - Newser
An undisclosed buyer entered into a definitive agreement to acquire Next Gen IP of Mainz Biomed N.V. for ?1.2 million. - marketscreener.com
QUCY|Mainz Biomed N V Ord Shs|Price:0.502|Chg%:-0.04 - TradingKey
QUCY|Mainz Biomed N V Ord Shs|Price:0.380|Chg%:-0.01 - TradingKey
QUCY|Mainz Biomed N V Ord Shs|Price:0.380|Chg%:0.02 - TradingKey
Finanzdaten der Mainz Biomed N V-Aktie (MYNZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):